The Impact of Intermittent Androgen Suppression Therapy in Prostate Cancer Modeling
Open Access
- 22 December 2018
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 9 (1) , 36
Abstract
Previous studies on prostate cancer modeling under hormonal therapy successfully fit clinical serum androgen data, under the assumption that the levels of intracellular and serum androgen are similar. However, such an assumption may not hold throughout the course of treatment. In this paper, we propose a model that directly accounts for serum androgen and its interaction with intracellular androgen. We establish biological links between the model and clinical data, and discuss in detail parameter ranges and the initialization of model variables. We further investigate parameter sensitivity over time, which gauges the maximum effect of varying each parameter and allows us to fix some parameters, to increase the robustness of the parameter fitting process. By relying on the characteristics of intermittent androgen suppression therapy (IAS), we employ a two-part weighted error function for fitting. We also carry out mathematical analyses to study the dynamic aspects of the system with different androgen thresholds. We find that the proposed model shows superior forecasting ability, compared to its predecessor. Furthermore, we demonstrate the impact of androgen on the dynamics of the androgen-dependent and -independent cancer cells, which suggests the discrete description of androgen dependency may not give a realistic characterization of the cancer population. We show that IAS has certain characteristics that need to be considered for parameter estimation. Our results demonstrate that the model and the fitting scheme are viable for similar applications of prostate cancer modeling under hormonal therapy.Keywords
Funding Information
- National Science Foundation (DMS-1518529 and 1148771)
This publication has 23 references indexed in Scilit:
- Cancer statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- Predicting time to castration resistance in hormone sensitive prostate cancer by a personalization algorithm based on a mechanistic model integrating patient dataThe Prostate, 2015
- Comparison between mathematical models of intermittent androgen suppression for prostate cancerJournal of Theoretical Biology, 2015
- Can Mathematical Models Predict the Outcomes of Prostate Cancer Patients Undergoing Intermittent Androgen Deprivation Therapy?Biophysical Reviews and Letters, 2014
- A clinical data validated mathematical model of prostate cancer growth under intermittent androgen suppression therapyAIP Advances, 2012
- Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancerJournal of Theoretical Biology, 2010
- MATHEMATICAL MODELING OF PROSTATE TUMOR GROWTH UNDER INTERMITTENT ANDROGEN SUPPRESSION WITH PARTIAL DIFFERENTIAL EQUATIONSInternational Journal of Bifurcation and Chaos, 2008
- A Mathematical Model of Intermittent Androgen Suppression for Prostate CancerJournal of Nonlinear Science, 2008
- Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancerCancer, 2006
- A mathematical model of prostate tumor growth and androgen-independent relapseDiscrete and Continuous Dynamical Systems-Series B, 2004